Liu et al. demonstrated that drug resistance in epithelial ovarian cancer (EOC) cells may be associated with increased aldehyde dehydrogenase (ALDH) activity, possibly because PARP inhibitors induce increased BRD4 expression. The gene discussed is PARP1; the disease is ovarian carcinoma.